Insider plans Rule 144 sale of 5,455 shares

An affiliate of OCUL has filed a Rule 144 notice to sell 5,455 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC on the NASDAQ market.

Accepted by SEC EDGAR 02/02/2026 - 04:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An affiliate of OCUL has filed a Rule 144 notice to sell 5,455 shares of the issuer’s common stock through Morgan Stanley Smith Barney LLC on the NASDAQ market. The shares have an indicated aggregate market value of $49,872.88 and were acquired on 01/30/2026 via restricted stock vesting under a registered plan. Common shares outstanding were 213,047,472 as of the filing, providing context for the planned sale size.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OCUL Form 144 filing disclose?

The filing discloses an affiliate’s intent to sell 5,455 OCUL common shares under Rule 144. The planned sale, valued at $49,872.88, will be executed through Morgan Stanley Smith Barney LLC on NASDAQ following acquisition via restricted stock vesting.

How many OCUL shares are planned for sale under this Rule 144 notice?

The Rule 144 notice covers the planned sale of 5,455 OCUL common shares. These shares have an aggregate market value of $49,872.88 based on the filing’s data and will be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

How were the OCUL shares being sold under Rule 144 acquired?

The shares were acquired on 01/30/2026 through restricted stock vesting under a registered plan with the issuer. The filing states that 5,455 common shares vested from the issuer, with “Not Applicable” listed as the nature of payment for the acquisition.

What is the approximate sale date for the OCUL Rule 144 shares?

The notice lists an approximate sale date of 02/02/2026 for the 5,455 OCUL common shares. This date reflects when the broker, Morgan Stanley Smith Barney LLC, may begin selling the shares on NASDAQ, consistent with Rule 144 requirements.

How many OCUL shares are outstanding compared to the Rule 144 sale amount?

The issuer had 213,047,472 common shares outstanding, according to the filing. The Rule 144 notice covers 5,455 shares, providing a baseline context for the relative size of the contemplated sale versus total shares outstanding.

Which broker will handle the OCUL Rule 144 stock sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists its address as 1 New York Plaza, 8th Floor, New York, NY 10004, and identifies NASDAQ as the securities exchange for the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001718019
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OCULAR THERAPEUTIX, INC.
SEC File Number	001-36554
Address of Issuer	15 Crosby Drive Bedford MASSACHUSETTS 01730
Phone	781-357-4000
Name of Person for Whose Account the Securities are To Be Sold	DONALD D NOTMAN JR.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5455	49872.88	213047472	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Restricted stock vesting under a registered plan	Issuer			5455	01/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Donald D Notman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)